119 related articles for article (PubMed ID: 10914560)
1. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
[No Abstract] [Full Text] [Related]
2. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
3. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
[TBL] [Abstract][Full Text] [Related]
4. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
Sola B; Salaün V; Ballet JJ; Troussard X
Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Igawa T; Sato Y; Takata K; Fushimi S; Tamura M; Nakamura N; Maeda Y; Orita Y; Tanimoto M; Yoshino T
Cancer Sci; 2011 Nov; 102(11):2103-7. PubMed ID: 21790895
[TBL] [Abstract][Full Text] [Related]
7. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
8. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
[TBL] [Abstract][Full Text] [Related]
10. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Bosch F; Jares P; Campo E; Lopez-Guillermo A; Piris MA; Villamor N; Tassies D; Jaffe ES; Montserrat E; Rozman C
Blood; 1994 Oct; 84(8):2726-32. PubMed ID: 7919385
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
12. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
13. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
Nakamura S; Seto M; Banno S; Suzuki S; Koshikawa T; Kitoh K; Kagami Y; Ogura M; Yatabe Y; Kojima M
Jpn J Cancer Res; 1994 Dec; 85(12):1270-9. PubMed ID: 7531681
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 protein expression in mantle cell lymphoma.
Alkan S; Schnitzer B; Thompson JL; Moscinski LC; Ross CW
Ann Oncol; 1995 Jul; 6(6):567-70. PubMed ID: 8573535
[TBL] [Abstract][Full Text] [Related]
16. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein and chronic lymphocytic leukemia.
Friday E; Koshy N; Bhanderi V; Turturro F
Leuk Lymphoma; 2012 Mar; 53(3):492-4. PubMed ID: 21916829
[No Abstract] [Full Text] [Related]
19. Overexpression of cyclin D2 in chronic B-cell malignancies.
Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
[TBL] [Abstract][Full Text] [Related]
20. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
